|
|
|
Hilton Boston Back Bay, 40 Dalton Street, Boston, MA 02115
October 29-30, 2014
The rapid expansion of tick-borne illness in the Americas and Europe poses great challenges for the prevention and treatment of these diseases, in both humans and animals. Though Lyme Disease continues to be the predominant disease (with estimates of as many as 300,000 new cases every year in the US), new and emerging illnesses are increasingly reported. The cost for treatment of these diseases continues to rise. As humans and animals spend more time in wooded areas, the threat becomes even more urgent. This conference will address the newest science in the pathogenesis of these diseases, along with the latest research into prevention and treatment of these crippling illnesses.
BREAKING NEWS IN THE SCIENCE - Bacterial and Viral Co-Infections in Wisconsin Tick Population
Brian D. Curry, Ph.D., MBA, President, Coppe Healthcare Solutions, Inc.
- Antibodies to Endothelial Cell Growth Factor and Obliterative Microvascular Lesions in Synovia of Patients with Antibiotic-Refractory Lyme Arthritis
Allen C. Steere, M.D., Professor, Rheumatology, Allergy & Immunology, Massachusetts General Hospital and Harvard Medical School
EMERGING DIAGNOSTICS - Next Generation Diagnostic Test for Lyme Disease
Benjamin Luft, M.D., Professor, Medicine, Stony Brook University
- Performance of United States Serologic Assays in the Diagnosis of Lyme Borreliosis Acquired in Europe
John A. Branda, Ph.D., Microbiology Laboratory, Massachusetts General Hospital
- Sensitive Multiplex PCR Assay to Detect Lyme Spirochetes, Anaplasmaphagocytophilum and Babesiamicroti
Nikhat Parveen, Ph.D., Associate Professor, Department of Microbiology and Molecular Genetics, Rutgers-New Jersey Medical School
- Assessment of New Culture Method for Detectionof Borrelia Species from Serum of Lyme Disease Patient
Mark A. Pilgard, Ph.D., Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado
PROMISING TREATMENTS - Old Tricks and New Trends in Diagnosis of Rickettsial Diseases: From the Lab Bench to the Bedside
Marina Eremeeva, M.D., Ph.D., D.Sc., Associate Professor, Core Lab Director, Environmental Health Sciences, GSU
- Topical and Non-Topical Treatment of Lyme disease Shortly after a Tick Bite
Charles Pavia, Ph.D., Academic Scientist-Professor, Biomedical Sciences, NYIT College of Osteopathic Medicine and New York Medical College
- Reservoir Targeted Protective Immunization against Lyme Disease (B. burgdorferi) Transmission in Miceby Oral Bait Containing ExpressTec-Made Fusion Protein Antigen
Chris MacManus, Scientist, Research and Development, Ventria Biosciences
|
|
|
|
|
|
Organized by:
|
|
Cambridge Healthtech Institute (CHI) |
|
Invited Speakers:
|
|
- Brian D. Curry, Ph.D., MBA, President, Coppe Healthcare Solutions, Inc.
- Allen C. Steere, M.D., Professor, Rheumatology, Allergy & Immunology, Massachusetts General Hospital and Harvard Medical School
- Benjamin Luft, M.D., Professor, Medicine, Stony Brook University
- John A. Branda, Ph.D., Microbiology Laboratory, Massachusetts General Hospital
- Nikhat Parveen, Ph.D., Associate Professor, Department of Microbiology and Molecular Genetics, Rutgers-New Jersey Medical School
- Mark A. Pilgard, Ph.D., Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado
- Marina Eremeeva, M.D., Ph.D., D.Sc., Associate Professor, Core Lab Director, Environmental Health Sciences, GSU
- Charles Pavia, Ph.D., Academic Scientist-Professor, Biomedical Sciences, NYIT College of Osteopathic Medicine and New York Medical College
- Chris MacManus, Scientist, Research and Development, Ventria Biosciences
|
|
|
|
|
|
Deadline for Abstracts:
|
|
---
|
|
|
|
|
|
Registration:
|
|
Register Now
|
|
E-mail:
|
|
kwaterman@healthtech.com
|
|
|
|
|
|
|
|